
Puppy's Mystery Illness Perplexes Owners for 5 Years—Then a Theory Emerges
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
A puppy's mystery illness, which left her with severely swollen eyes, has struck a nerve among viewers online, sparking a flood of responses and a wave of speculation from fellow pet owners about the unexplained condition.
Asia, a three-legged chocolate Labrador retriever from Yorkshire, England, captured the attention of millions on TikTok when her owner, Jared Power, shared haunting photos of the mysterious illness she went through five years go to the platform.
The images, posted July 2 under @asia.the.choccy, have been viewed more than 1.9 million times and liked by over 62,000 users to date.
Viewers were able to see then-puppy Asia struggling with puffed-up eyes and an unclear diagnosis, set to on-screen text reading, "we came home from work to find our dog like this … She was still a puppy at the time … We took her to the emergency vets … Some medicine to reduce the swelling … Five years later, still no clue what caused this."
Speaking to Newsweek, Power, who owns Asia with his partner Scott Oldridge, recalled the night that began what remains an unsolved mystery.
"We had just come home from a shift at work to find something had happened to our dog Asia; she was still a little puppy at the time," Power said. "Her eyes had swollen, and she was not feeling very well at all.
"This was quite late at night, so we had to rush her into the emergency vets," Power added.
The medical team provided treatment to reduce the swelling but was unable to offer a concrete diagnosis.
"This was such a scary situation as Asia was still so young, and nothing had happened like this before," Power said. "The vets could not give a definite answer to what caused this leading to my TikTok post as I wanted to find my own answers."
Asia made a full recovery, and the episode was never repeated, but the mystery has lingered for years. TikTok users quickly responded to the photos, with many sharing stories of their own dogs experiencing similar unexplained reactions.
"Hundreds of comments flooded in from other dog owners, including photo comments too, sharing their experiences and similar stories of their dogs having reactions like this and never finding out what caused it," Power added.
From left: Asia the chocolate Labrador looks at the camera during her mystery illness; and afterwards.
From left: Asia the chocolate Labrador looks at the camera during her mystery illness; and afterwards.
@asia.the.choccy
Theories from commenters range widely, suggesting everything from insect stings to food allergies.
"Happened to my puppy when we got her 3 years ago, the vet luckily caught on that it was something called 'puppy strangles'," one viewer said. Several commenters mentioned "puppy strangles," an uncommon skin condition that can affect young dogs.
"My dog's whole face was swollen one day like this," another viewer added. "Turns out she was allergic to the down feather pillows we had."
"There are also lots of theories ranging from bee or wasp stings, spider bites, allergies to all sorts including carpets, pollen, air fresheners, cleaning products, even chicken, pork; and someone even said vaccinations," Power said.
Though the episode remains unexplained, Power said that Asia is currently thriving.
"Asia is all good now and doing well," the owner said. "However, recently she was diagnosed with cancer at 5 years old, a histiocytic sarcoma in her back paw, and the leg was amputated.
"She has been given the all clear of cancer and is living the best happy life ever," Power said.
Asia, now 6, continues to appear in TikTok videos under @asia.the.choccy that document her recovery and day-to-day life with her owners. And despite the traumatic memory, Power said he was stunned by how widely the post about her past mystery illness resonated.
"I went to bed last night, and the post went to 1 million views," he said. "I was shocked when I woke up in the morning."
Do you have funny and adorable videos or pictures of your pet you want to share? Send them to life@newsweek.com with some details about your best friend, and they could appear in our Pet of the Week lineup.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
2 hours ago
- Newsweek
Biden's Ex-Doctor Calls House GOP's Move 'Unprecedented and Alarming'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Dr. Kevin O'Connor, former President Joe Biden's White House physician, has requested a delay in his scheduled testimony before the House Oversight Committee, citing concerns over doctor-patient confidentiality. O'Connor's lawyer, David Schertler, described the committee's refusal to accommodate any privacy protections as "unprecedented" and "alarming," warning that his client could face "serious consequences," including the loss of his medical license. In a letter sent Saturday to Committee Chair Rep. James Comer (R-Ky.), O'Connor's attorney asked for a postponement until late July or early August to allow time for an agreement that would "protect the very substantial privilege and confidentiality interests of Dr. O'Connor and former President Biden." The Associated Press obtained a copy of the letter. The request comes as House Republicans intensify their investigation into Biden's health and mental fitness during his time in office—a probe with potential political and legal ramifications. The Oversight Committee has rejected O'Connor's bid to delay the subpoena, stating that witnesses must appear and may assert privilege on a question-by-question basis. Comer has argued that physician-patient confidentiality does not override a congressional subpoena, claiming that the American Medical Association's ethics code "lacks merit" under federal law. The dispute is part of a wider inquiry involving subpoenas and testimony from a dozen former Biden aides, as Republicans seek to determine whether any official actions, including those signed by "autopen," were executed while Biden was allegedly incapacitated—claims the former president has called "ridiculous and false." This is a breaking news story. Updates to follow. This article includes reporting by the Associated Press.


Newsweek
2 hours ago
- Newsweek
Donald Trump's 'Big, Beautiful Bill' Suffers Legal Blow
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. On Monday, Judge Indira Talwani, a federal judge in Boston, issued a temporary restraining order against President Donald Trump's "big, beautiful bill's" provision to defund Planned Parenthood. Planned Parenthood filed a lawsuit Monday against the Trump administration, challenging a provision in the Republican president's broad domestic policy legislation that would block its health centers from receiving Medicaid reimbursements. This is a breaking news story. Updates to follow.
Yahoo
4 hours ago
- Yahoo
Novo and Lilly compete in India as obesity drugs demand hikes
STORY: :: Eli Lilly Demand for weight-loss drugs in India has shot up. And rivals Novo Nordisk and Eli Lilly are battling for market share. That's according to research firm Pharmarack. It said sales of Lilly's Mounjaro, which launched in March, doubled from May to June. Overall, it's almost hit close to 88,000 units sold - over $3 million. :: Novo Nordisk Meanwhile, Pharmarack said Novo sold almost 1,800 units of Wegovy since its late-June launch. Medical journal the Lancet has said the incidence of obesity and diabetes is rising in India. And the country ranks among the worst three globally for high obesity rates. Pharmarack said the Indian obesity market has grown fivefold since 2021 and is valued at $73 million. And affordability and willingness to try new drugs for obesity have propelled the growth of the market. While Wegovy's only just launched, the active ingredient in it - semaglutide - has a two-thirds share in the Indian market, according to Pharmarack. And Novo has sold oral versions of semaglutide for diabetes in India since 2022. However, semaglutide will lose patent protection in India next year. Enabling generic drugmakers to produce cheaper versions of Wegovy as India becomes a key battleground for drugmakers in the global obesity market. Error al recuperar los datos Inicia sesión para acceder a tu cartera de valores Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos